Biocon nears 52-week low, falls 5% after reporting mixed numbers in Q4

Biocon shares were quoting lower for the third straight day, down 5 per cent at Rs 561 in intra-day trade on the BSE, after the company reported mixed numbers for the quarter ended March 2019 (Q4FY19).

In the past three trading days, the stock has slipped 10 per cent, as compared to a per cent rise in the benchmark S&P BSE Sensex. It is trading close to its 52-week low price of Rs 544 on July 7, 2018, on the BSE in intra-day deal.

Biocon posted 30.7 per cent year-on-year (YoY) growth in consolidated revenues at Rs 1,529